A synthesis comparison found similar crude purity for the same sequence across flow and batch methods.
What the study actually tested
Researchers used in-line UV data from flow solid-phase peptide synthesis (SPPS) to investigate sequence-dependent aggregation and compared selected products with batch SPPS. For a non-aggregating 68-residue NBDY construct, they reported 63% crude purity by automated flow and 66% by batch under their tested conditions. For aggregating Barstar[75–90], both methods gave roughly 55% crude purity with similar side-product profiles.
Numbers worth reading in context
| Study measure | Reported result |
|---|---|
| NBDY flow | 63% crude purity |
| NBDY batch | 66% crude purity |
| Barstar both | ~55% crude purity |
These numbers are not a benchmark for all peptides. They show that simply changing the platform may not erase a sequence-specific difficulty. The authors used peak-shape changes during Fmoc deprotection to locate aggregation behavior; they did not claim that an online trace alone proves final identity or release purity. Crude purity also differs from the amount and purity of a purified final lot.
What to put in the RFQ or experiment plan
For a long or aggregation-prone custom peptide, request a feasibility discussion around sequence, protecting groups, resin, coupling strategy, purification goal, and expected reporting. Define which value is being quoted: crude composition, final chromatographic purity, isolated mass, or net peptide content. If a supplier proposes a different synthesis route, ask how it changes the required analytical evidence.
Evidence boundary
The 63%, 66%, and ~55% values come from two published constructs and specific methods. They are not predicted NHD yields or a promise that a difficult customer sequence will meet the same numbers.
Sources and next step
Primary research: A robust data analytical method to investigate sequence dependence in flow-based peptide synthesis. These external figures are not test results for an NHD lot.
Related NHD guide: read the related article. For a material-specific question, request a written quotation with the sequence, amount, intended use, and required records.
Sources & editorial method
AI-assisted writing and source verification. Numerical claims were checked against the linked full-text records, with source inconsistencies identified in the article. This is not independent scientific peer review or verification of a supplied lot.
1 linked records are listed in the references below. Read the editorial and AI-assistance policy.
How to interpret this article
The 63%, 66%, and ~55% values come from two published constructs and specific methods. They are not predicted NHD yields or a promise that a difficult customer sequence will meet the same numbers.
Research-use boundary: Catalog materials discussed on this website are for laboratory research, development and manufacturing use only, not for human or veterinary use. This content is not medical advice and does not provide administration instructions.
